Andrew Brenyo is a Cardiology physician. OpenAlex indexes 38 publications with 943 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
196 Cardiology Dr
Rock Hill, SC 297321174
Telephone
803-324-5135Provider last certified this registry record 24 Apr 2024.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BIOTRONIK INC.Program year202528 payments$11,784openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202516 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
70.1%Beta blocker18.5%Metoprolol Succinate40%Carvedilol25%Metoprolol Tartrate20%Sotalol12%Atenolol3%Part D<11 patientsStatin11.7%Rosuvastatin Calcium44%Atorvastatin Calcium39%Simvastatin9%Pravastatin Sodium8%Part D≥84 patients+ 12 more classes in this area
Blood & clotting
24.6%Factor Xa inhibitor18%Eliquis85%Xarelto16%Part D≥161 patientsP2Y12 inhibitor6.6%Clopidogrel100%Part D≥113 patientsMetabolism & gastrointestinal
5.3%Proton pump inhibitor2.2%Pantoprazole Sodium64%Omeprazole37%Part D≥24 patientsPotassium supplement1.8%Potassium Chloride100%Part D≥26 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Efficacy of a Novel Sealant‐Based Vascular Closure Device Following Electrophysiology Procedures: ReliaSeal Trial
Journal of Cardiovascular Electrophysiology
2025 - TCT-999 ReliaSeal Trial: A Randomized Trial of Multiple Venous Access Closure With MYNX CONTROL™ VENOUS Vascular Closure Device and Manual Compression After Catheter-Based Ablation Procedures
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”